Tesidolumab( —— )

Catalog No. M36737 CAS No. 1531594-08-7

Tesidolumab (LFG316) is a fully human IgG1/λ anti-C5 monoclonal antibody.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	471	In Stock
10MG	787	In Stock
25MG	1169	In Stock
50MG	1535	In Stock
100MG	2074	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Tesidolumab
Note

Research use only, not for human use.
Brief Description

Tesidolumab (LFG316) is a fully human IgG1/λ anti-C5 monoclonal antibody.
Description

Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.
In Vitro

Tesidolumab (LFG316) possesses a half-life in humans of approximately 9 days.Tesidolumab (LFG316) binds to a distinct epitope to that of eculizumab and ravulizumab, distant to Arg 885.
In Vivo

——
Synonyms

——
Pathway

Immunology/Inflammation
Target

Complement System
Recptor

Complement System
Research Area

——
Indication

——

Chemical Information

CAS Number

1531594-08-7
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Jun-Ichi Nishimura, et al. Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria. Haematologica. 2022 Jun 1;107(6):1483-1488.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks